Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Elicio Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- 0 vs. Q1 2021
- Shares held
- 5.03M
- −86.2K (−1.7%) vs. Q1 2021
- Total value
- $66.5M
- −$25.4M (−27.7%) vs. Q1 2021
- New holders
- 5
- 11 more added
- Sold out
- 5
- 15 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCI Wealth Advisors, Inc. | 37 | $0 | 0.00% | +37 | New |
| Wells Fargo & Company | 100 | $1.00K | 0.00% | −1,810−94.8% | Reduced |
| Toth Financial Advisory Corp | 150 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 217 | $3.00K | 0.00% | −1,413−86.7% | Reduced |
| Citigroup Inc | 276 | $4.00K | 0.00% | −109−28.3% | Reduced |
| Royal Bank of Canada | 397 | $5.00K | 0.00% | −167−29.6% | Reduced |
| Ameritas Investment Partners, Inc. | 472 | $6.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 570 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,091 | $14.0K | 0.00% | +359+49.0% | Added |
| American International Group, Inc. | 3,253 | $42.0K | 0.00% | −131−3.9% | Reduced |
| Deutsche Bank AG | 3,547 | $46.0K | 0.00% | −111−3.0% | Reduced |
| New York State Common Retirement Fund | 5,746 | $75.0K | 0.00% | +2,846+98.1% | Added |
| California State Teachers Retirement System | 8,045 | $105.0K | 0.00% | −711−8.1% | Reduced |
| Bank of America Corp | 9,114 | $119.0K | 0.00% | −8,619−48.6% | Reduced |
| CAPROCK Group, Inc. | 15,726 | $205.0K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 23,864 | $311.0K | 0.00% | −11,092−31.7% | Reduced |
| Ergoteles LLC | 23,917 | $311.0K | 0.01% | +23,917 | New |
| Morgan Stanley | 27,396 | $357.0K | 0.00% | +26,449+2,792.9% | Added |
| Alyeska Investment Group, L.P. | 32,239 | $420.0K | 0.00% | −17,761−35.5% | Reduced |
| Charles Schwab Investment Management Inc | 33,210 | $433.0K | 0.00% | −1,608−4.6% | Reduced |
| STRS Ohio | 35,500 | $462.0K | 0.00% | +34,100+2,435.7% | Added |
| Millennium Management LLC | 48,059 | $626.0K | 0.00% | +14,799+44.5% | Added |
| BLB&B Advisors, LLC | 56,847 | $740.0K | 0.05% | +56,847 | New |
| Jacobs Levy Equity Management, Inc | 57,146 | $744.0K | 0.01% | +57,146 | New |
| HRT Financial LP | 59,857 | $779.0K | 0.01% | +59,857 | New |
| Knoll Capital Management, LLC | 60,000 | $781.0K | 0.41% | 00.0% | Unchanged |
| Northern Trust Corp | 64,531 | $839.0K | 0.00% | −193−0.3% | Reduced |
| Victory Capital Management Inc | 77,460 | $1.01M | 0.00% | −5,160−6.2% | Reduced |
| State Street Corp | 85,405 | $1.11M | 0.00% | +38,400+81.7% | Added |
| CM Management, LLC | 93,750 | $1.22M | 0.88% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 101,290 | $1.32M | 0.00% | +5,984+6.3% | Added |
| Nantahala Capital Management, LLC | 125,000 | $1.63M | 0.09% | 00.0% | Unchanged |
| Birchview Capital, LP | 60,615 | $1.94M | 1.16% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 187,116 | $2.44M | 0.00% | +7,628+4.2% | Added |
| Stonepine Capital Management, LLC | 222,836 | $2.90M | 1.52% | +87,852+65.1% | Added |
| Vanguard Group Inc | 252,292 | $3.29M | 0.00% | −519,643−67.3% | Reduced |
| BlackRock Inc. | 281,044 | $3.66M | 0.00% | −32,669−10.4% | Reduced |
| FMR LLC | 312,500 | $4.07M | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 615,000 | $8.01M | 0.00% | 00.0% | Unchanged |
| Park West Asset Management LLC | 1,006,289 | $13.0M | 0.38% | +39,635+4.1% | Added |
| BVF Inc | 1,036,500 | $13.5M | 0.51% | +161,500+18.5% | Added |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −66,376−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −21,875−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −10,417−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −209−100.0% | Sold out |